NCT01476007View on ClinicalTrials.gov

Oral/Intramuscular B12 to Treat Cobalamin Deficiency

NACompletedINTERVENTIONAL
Enrollment

284

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

November 28, 2017

Study Completion Date

November 28, 2017

Conditions
Vitamin B 12 Deficiency
Interventions
DRUG

oral Cobalamin (vitamin B12)

Intervention group: oral Optovite® B12 1000 gammas.

DRUG

intramuscular Cobalamin (vitamin B12)

Control group: intramuscular Optovite® B12 1000 gammas.

Trial Locations (1)

28035

Gerencia Atención Primaria, Madrid, Madrid

All Listed Sponsors
collaborator

Instituto de Salud Carlos III

OTHER_GOV

lead

Gerencia de Atención Primaria, Madrid

OTHER_GOV

NCT01476007 - Oral/Intramuscular B12 to Treat Cobalamin Deficiency | Biotech Hunter | Biotech Hunter